
RGNX
USDREGENXBIO Inc. Common Stock
$11.560+0.140 (1.226%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$11.420
High
$11.955
Low
$11.375
Volume
0.20M
Company Fundamentals
Market Cap
583.9M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.60M
Exchange
NMS
Currency
USD
52-Week Range
Low $5.035Current $11.560High $13.925
Related News
PR Newswire
REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program
REGENXBIO Inc. (Nasdaq: RGNX) today announced the completion of enrollment in the AFFINITY DUCHENNE® pivotal trial of RGX-202, an investigational...
View more
PR Newswire
REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights
REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Thursday, November 6, at 8:00 a.m. ET to discuss its financial...
View more
PR Newswire
REGENXBIO to Participate in Upcoming Investor Conferences
REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences: Chardan's 9th Annual Genetic Medicines...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.